Sanofi SA (NASDAQ:SNY)
| 46.55 Delayed Data As of Mar 05 |  +0.65 / +1.42%Today’s Change | 37.62 Today|||52-Week Range 55.00 | -4.20% Year-to-Date |
Latest SNY News | Press Releases
Today’s Trading
| Previous close | 45.90 |
| Today’s open | 46.18 |
| Day’s range | 46.02 - 46.64 |
| Volume | 41,930 |
| Average volume (3 months) | 2,293,180 |
| Market cap | $116.4B |
Data as of 3:59pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | +330.16% |
| Earnings growth (this year) | +5.54% |
| Earnings growth (next 5 years) | +7.17% |
| Revenue growth (last year) | +1.61% |
| P/E ratio | 8.8 |
| Price/Sales | 2.97 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.45 | +0.65% |
| AZNAstraZeneca | +0.83 | +1.76% |
| BMYBristol-Myers Squibb | +1.09 | +1.84% |
| GSKGlaxoSmithKline | +0.62 | +1.81% |
Data as of 4:00pm ET, 03/05/2021
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $14.0B |
| Net profit margin | 34.17% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
